Structure Analysis of Membrane-Active Peptides Using 19F-Labeled Amino Acids and Solid-State NMR

Fluorine in Medicinal Chemistry and Chemical Biology

Volumn , Issue , 2009, Pages 463-493

  Wadhwani, Parvesh ^a   Strandberg, Erik ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Antimicrobial peptides (AMPs) or host defense peptides; F NMR analysis of different membrane active peptides in lipid bilayers; Membrane active peptides; Solid phase peptide synthesis; Structure analysis of membrane active peptides; Structure and orientation of peptides in membranes

Indexed keywords

EID: 74249123829     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444312096.ch18     Document Type: Chapter

References (110)

1. Kukhar, V. P. and Soloshonok, V. A. (1995) Fluorine-Containing Amino Acids: Synthesis and Properties, John Wiley & Sons. Ltd, Chichester, New York.
2. Soloshonok, V. A., Mikami, K., Yamazaki, T., et al. (eds.) (2007) Current Fluoroorganic Chemistry: New Synthetic Directions, Technologies, Materials, and Biological Applications. American Chemical Society, Washington, DC.
3. Grage, S. L., Salgado, J. B., Dürr, U. H. N., et al. (2001) Solid state 19F-NMR of biomembranes, in Perspectives on Solid State NMR in Biology (eds. S. R. Kiihne and H. J. M. de Groot), Kluwer Academic Publishers, Dordrecht/Boston/London, pp. 83-91.
4. Strandberg, E. and Ulrich, A. S. (2004) NMR methods for studying membrane-active antimicrobial peptide. Concepts in Magnetic Resonance Series A, 23A, 89-120.
5. Ulrich, A. S., Wadhwani, P., Dürr, U. H. N., et al. (2006) Solid-state 19F-nuclear magnetic resonance analysis of membrane- active peptides, in NMR Spectroscopy of Biological Solids (ed. A. Ramamoorthy), CRC Press, Boca Raton, FL, pp. 215-236.
6. Ulrich, A. S. (2005) Solid state 19F-NMR methods for studying biomembranes. Progress in Nuclear Magnetic Resonance Spectroscopy, 46, 1-21.
7. Wadhwani, P., Tremouilhac, P., Strandberg, E., et al. (2007) Using fluorinated amino acids for structure analysis of membrane-active peptides by solid- state 19F-NMR, in Current Fluoroor-ganic Chemistry: New Synthetic Directions, Technologies, Materials, and Biological Applications (eds. V. A. Soloshonok, K. Mikami, T. Yamazaki, et al.), American Chemical Society, Washington, D.C., pp. 431-146.
8. Levine-Pinto, H., Bouabdallah, B., Morgat, J. L., et al. (1981) Specific and direct fluorination of an histidine-containing peptide: thyroliberin. Biochemical and Biophysical Research Communications, 103, 1121-1130.
9. Sutherland, A. and Willis, C. L. (2000) Synthesis of fluorinated amino acids. Natural Product Reports, 17, 621-631.
10. Qiu, X. L., Meng, W. D. and Qing, F. L. (2004) Synthesis of fluorinated amino acids. Tetrahedron, 60, 6711-6745.
11. Israelachvili, J. N., Mitchell, D. J. and Ninham, B. W. (1977) Theory of self-assembly of lipid bilayers and vesicles. Biochimica et Biophysica Acta, 470, 185-201.
12. Jaeckel, C. and Koksch, B. (2005) Fluorine in peptide design and protein engineering. European Journal of Organic Chemistry, 2005, 4483-4503.
13. Tang, Y., Ghirlanda, G., Petka, W. A., et al. (2001) Fluorinated coiled-coil proteins prepared in vivo display enhanced thermal and chemical stability. Angewandte Chemie International Edition, 40, 1494-1496.
14. Bilgicer, B., Fichera, A. and Kumar, K. (2001) A coiled coil with a fluorous core. Journal of the American Chemical Society, 123, 4393-4399.
15. Tang, Y., Ghirlanda, G., Vaidehi, N., et al. (2001) Stabilization of coiled-coil peptide domains by introduction of trifluoroleucine. Biochemistry, 40, 2790-2796.
16. Tang, Y. and Tirrell, D. A. (2001) Biosynthesis of a highly stable coiled-coil protein containing hexafluoroleucine in an engineered bacterial host. Journal of the American Chemical Society, 123, 11089-11090.
17. Danielson, M. A. and Falke, J. J. (1996) Use of 19F NMR to probe protein structure and con-formational changes. Annual Review of Biophysics and Biomolecular Structures, 25, 163-195.
18. Gerig, J. T. (1994) Fluorine NMR of proteins. Progress in Nuclear Magnetic Resonance Spec- troscopy, 26, 293-370.
19. Sun, S.-Y., Pratt, E. A. and Ho, C. (1996) 19F-labeled amino acids as structural and dynamic probes in membrane- associated proteins, in Biomedical Frontiers of Fluorine Chemistry (eds. I. Ojima, J. R. McCarthy and J. T. Welch), American Chemical Society, Washington, D.C., pp. 296-310.
20. Salopek-Sondi, B. and Luck, L. A. (2002) 19F NMR study of the leucine-specific binding protein of Escherichia coli. mutagenesis and assignment of the 5-fluorotryptophan-labeled residues. Protein Engineering, 15, 855-859.
21. Luck, L. A. and Johnson, C. (2000) Fluorescence and 19F NMR evidence that phenylalanine, 3-L-fluorophenylalanine and 4-L-fluorophenylalanine bind to the L-leucine specific receptor of Escherichia coli. Protein Science, 9, 2573-2576.
22. Luck, L. A., Vance, J. E., O'Connell, T. M. and London, R. E. (1996) 19F NMR relaxation studies on 5-fluorotryptophan- and tetradeutero-5-fluorotryptophan-labeled E. coli glucose/galactose receptor. Journal of Biomolecular NMR, 7, 261-272.
23. Strandberg, E., Tiltak, D., Ieronimo, M., et al. (2007) Influence of C-terminal amidation on the antimicrobial and hemolytic activities of cationic a-helical peptides. Pure and Applied Chemistry, 79, 717-728.
24. Langel, U. (2002) Cell-Penetrating Peptides: Processes and Applications, CRC Press, Boca Raton, FL.
25. Boman, H. G. (2003) Antibacterial peptides: basic facts and emerging concepts. Journal of Internal Medicine, 254, 197-215.
26. Reddy, K. V., Yedery, R. D. and Aranha, C. (2004) Antimicrobial peptides: premises and promises. International Journal of Antimicrobial Agents, 24, 536-547.
27. Brogden, K. A. (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nature Reviews on Microbiology, 3, 238-250.
28. Oren, Z. and Shai, Y. (1998) Mode of action of linear amphipathic a-helical antimicrobial peptides. Biopolymers, 47, 451-463.
29. Huang, H. W. and Wu, Y. (1991) Lipid-alamethicin interactions influence alamethicin orientation. Biophysical Journal, 60, 1079-1087.
30. Huang, H. W. (2000) Action of antimicrobial peptides: two- state model. Biochemistry, 39, 8347-8352.
31. Duchardt, F., Fotin-Mleczek, M., Schwarz, H., et al. (2007) A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic, 8, 848-866.
32. Fischer, R., Fotin-Mleczek, M., Hufnagel, H. and Brock, R. (2005) Break on through to the other side: biophysics and cell biology shed light on cell-penetrating peptides. Chembiochem, 6, 2126-2142.
33. Fischer, R., Kohler, K., Fotin-Mleczek, M. and Brock, R. (2004) A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides. Journal of Biological Chemistry, 279, 12625-12635.
34. Shai, Y. (2000) Functional domains within fusion proteins: prospectives for development of peptide inhibitors of viral cell fusion. Bioscience Reports, 20, 535-555.
35. Ragona, L., Molinari, H., Zetta, L., et al. (1996) CD and NMR structural characterization of ceratotoxins, natural peptides with antimicrobial activity. Biopolymers, 39, 653-664.
36. Andrushchenko, V. V., Vogel, H. J. and Prenner, E. J. (2006) Solvent-dependent structure of two tryptophan-rich antimicrobial peptides and their analogs studied by FTIR and CD spec-troscopy. Biochimica et Biophysica Acta, 1758, 1596-1608.
37. Mangoni, M. L., Papo, N., Mignogna, G., et al. (2003) Ranacyclins, a new family of short cyclic antimicrobial peptides: biological function, mode of action, and parameters involved in target specificity. Biochemistry, 42, 14023-14035.
38. Seto, G. W., Marwaha, S., Kobewka, D. M., et al. (2007) Interactions of the Australian tree frog antimicrobial peptides aurein 1.2, citropin 1.1 and maculatin 1.1 with lipid model membranes: Differential scanning calorimetric and Fourier transform infrared spectroscopic studies. Biochimica et Biophysica Acta, 1768, 2787-2800.
39. Huang, H. W. (2006) Molecular mechanism of antimicrobial peptides: the origin of cooperativ-ity. Biochimica et Biophysica Acta, 1758, 1292-1302.
40. Ladokhin, A. S., Selsted, M. E. and White, S. H. (1999) CD spectra of indolicidin antimicrobial peptides suggest turns, not polyproline helix. Biochemistry, 38, 12313-12319.
41. Ketchem, R. R., Hu, W. and Cross, T. A. (1993) High-resolution conformation of gramicidin A in a lipid bilayer by solid-state NMR. Science, 261, 1457-1460.
42. Kovacs, F., Quine, J. and Cross, T. A. (1999) Validation of the single-stranded channel conformation of gramicidin A by solid-state NMR. Proceedings of the National Academy of Sciences of the U. S. A., 96, 7910-7915.
43. Ketchem, R. R., Hu, W., Tian, F. and Cross, T. A. (1994) Structure and dynamics from solid state NMR spectroscopy. Structure, 2, 699-701.
44. Glaser, R. W., Sachse, C., Dürr, U. H. N., et al. (2005) Concentration-dependent realignment of the antimicrobial peptide PGLa in lipid membranes observed by solid- state 19F-NMR. Biophysical Journal, 88, 3392-3397.
45. Strandberg, E., Kanithasen, N., Tiltak, D., et al. (2008) Solid-State NMR analysis comparing the designer-made antibiotic MSI-103 with its parent peptide PGLa in lipid bilayers. Biochemistry, 47, 2601-2116.
46. Strandberg, E., Wadhwani, P., Tremouilhac, P., et al. (2006) Solid-state NMR analysis of the PGLa peptide orientation in DMPC bilayers: structural fidelity of 2H-labels versus high sensitivity of 19F-NMR. Biophysical Journal, 90, 1676-1686.
47. Tremouilhac, P., Strandberg, E., Wadhwani, P. and Ulrich, A. S. (2006) Conditions affecting the re-alignment of the antimicrobial peptide PGLa in membranes as monitored by solid state 2H-NMR. Biochimica et Biophysica Acta, 1758, 1330-1342.
48. Levitt, M. H. (2001) Spin Dynamics: Basics of Nuclear Magnetic Resonance. John Wiley & Sons Ltd, Chichester, New York.
49. Glaser, R. W., Sachse, C., Dürr, U. H. N., et al. (2004) Orientation of the antimicrobial peptide PGLa in lipid membranes determined from 19F-NMR dipolar couplings of 4-CF3-phenylglycine labels. Journal of Magnetic Resonance, 168, 153-163.
50. Afonin, S., Dürr, U. H. N., Glaser, R. W. and Ulrich, A. S. (2004) 'Boomerang'-like insertion of a fusogenic peptide in a lipid membrane revealed by solid- state 19F NMR. Magnetic Resonance in Chemistry, 42, 195-203.
51. Tremouilhac, P., Strandberg, E., Wadhwani, P. and Ulrich, A. S. (2006) Synergistic transmembrane alignment of the antimicrobial heterodimer PGLa/magainin. Journal of Biological Chemistry, 281, 32089-32094.
52. Moll, F., III and Cross, T. A. (1990) Optimizing and characterizing alignment of oriented lipid bilayers containing gramicidin D. Biophysical Journal, 57, 351-362.
53. Hallock, K. J., Wildman, K. H., Lee, D. K. and Ramamoorthy, A. (2002) An innovative procedure using a sublimable solid to align lipid bilayers for solid-state NMR studies. Biophysical Journal, 82, 2499-2503.
54. Glaser, R. W. and Ulrich, A. S. (2003) Susceptibility corrections in solid- state NMR experiments with oriented membrane samples. Part I: applications. Journal of Magnetic Resonance, 164, 104-114.
55. Strandberg, E., Özdirekcan, S., Rijkers, D. T. S., et al. (2004) Tilt angles of transmembrane model peptides in oriented and non-oriented lipid bilayers as determined by 2 H solid state NMR. Biophysical Journal, 86, 3709-3721.
56. Chiu, H. P., Suzuki, Y., Gullickson, D., et al. (2006) Helix propensity of highly fluorinated amino acids. Journal of the American Chemical Society, 128, 15556-15557.
57. Minks, C., Huber, R., Moroder, L. and Budisa, N. (2000) Noninvasive tracing of recombinant proteins with "fluorophenylalanine-fingers." Analytical Biochemistry, 284, 29-34.
58. Dunn, T. F. and Leach, F. R. (1967) Incorporation of p-fluorophenylalanine into protein by a cell-free system. Journal of Biological Chemistry, 242, 2693-2699.
59. Lian, C., Le, H., Montez, B., Patterson, J., et al. (1994) 19F nuclear magnetic resonance spectroscopic study of fluorophenylalanine- and fluorotryptophan-.abeled avian egg white lyso-zymes. Biochemistry, 33, 5238-5245.
60. Wang, P., Tang, Y. and Tirrell, D. A. (2003) Incorporation of trifluoroisoleucine into proteins in vivo. Journal of the American Chemical Society, 125, 6900-6906.
61. Fields, G. B. and Noble, R. L. (1990) Solid-phase peptide synthesis utilizing 9-fluorenylme-thoxycarbonyl amino acids. International Journal of Peptide and Protein Research, 35, 161-214.
62. Afonin, S., Glaser, R. W., Berditchevskaia, M., et al. (2003) 4-Fluorophenylglycine as a label for 19F-NMR structure analysis of membrane- associated peptides. Chembiochem, 4, 1151-1163.
63. Eisenhuth, R. (2003) Verbesserung der Kopplingseffizienz in der Peptidsynthese durch FEP, und Darstellung von 19F-markierten Peptiden, Diploma Thesis, University of Karlsruhe.
64. Morgan, J., Pinhey, J. T. and Sherry, C. J. (1997) Reaction of organolead triacetates with 4-ethoxycarbonyl-2-methyl-4,5-dihydro-1,3-oxazol-5-one. The synthesis of a-aryl- and a-vinyl-N-acetylglycines and their ethyl esters and their enzymic resolution. Journal of the Chemical Society Perkin Transactions 1, 613-619.
65. Chenault, H. K., Dahmer, J. and Whitesides, G. M. (1989) Kinetic resolution of unnatural and rarely occurring amino acids: enantioselective hydrolysis of N-acyl amino acids catalyzed by acylase I. Journal of the American Chemical Society, 111, 6354-6364.
66. Salgado, J., Grage, S. L., Kondejewski, L. H., et al. (2001) Membrane-bound structure and alignment of the antimicrobial ß-sheet peptide gramicidin S derived from angular and distance constraints by solid state 19F-NMR. Journal of Biomolecular NMR, 21, 191-208.
67. Mikhailiuk, P. K., Afonin, S., Chernega, A. N., et al. (2006) Conformationally rigid trifluoro-methyl-substituted a-amino acid designed forpeptide structure analysis by solid-state 19F NMR spectroscopy. Angewandte Chemie International Edition, 45, 5659-5661.
68. Afonin, S., Mikhailiuk, P. K., Komarov, I. V. and Ulrich, A. S. (2007) Evaluating the amino acid CF3-bicyclopentylglycine as a new label for solid- state 19F-NMR structure analysis of membrane-bound peptides. Journal of Peptide Science, 13, 614-623.
69. Fustero, S., Navarro, A., Pina, B., et al. (2001) Enantioselective synthesis of fluorinated a-amino acids and derivatives in combination with ring-closing metathesis: intramolecular n-stacking interactions as a source of stereocontrol. Organic Letters, 3, 2621-2624.
70. Crucianelli, M., Battista, N., Bravo, P., et al. (2002) Facile and stereoselective synthesis of non-racemic 3,3,3-trifluoroalanine. Molecules, 5, 1251-1258.
71. Toke, O., O'Connor, R. D., Weldeghiorghis, T. K., et al. (2004) Structure of (KIAGKIA)3 aggregates in phospholipid bilayers by solid- state NMR. Biophysical Journal, 87, 675-687.
72. Koksch, B., Sewald, N., Hofmann, H. J., et al. (1997) Proteolytically stable peptides by incorporation of alpha-Tfm amino acids. Journal of Peptide Science, 3, 157-167.
73. Maisch, D. (2008) Synthese und Strukturuntersuchungen des membranaktiven Peptaibols Alamethicin mittels 19F-Festkö'rper-NMR, Ph.D. thesis, University of Karlsruhe.
74. Grage, S. L., Wang, J., Cross, T. A. and Ulrich, A. S. (2002) Structure analysis of fluorine-labelled tryptophan side-chains in gramicidin A by solid state 19F-NMR. Biophysical Journal, 83, 3336-3350.
75. Witter, R., Nozirov, F., Sternberg, U., et al. (2008) Solid-state 19F NMR spectroscopy reveals that Trp41 participates in the gating mechanism of the M2 proton channel of influenza A virus. Journal of the American Chemical Society, 130, 918-924.
76. Cotten, M., Tian, C., Busath, D. D., et al. (1999) Modulating dipoles for structure- function correlations in the gramicidin A channel. Biochemistry, 38, 9185-9197.
77. Gause, G. F. and Brazhnikova, M. G. (1944) Gramicidin S. and its use in the treatment of infected wounds. Nature, 154, 703.
78. Gause, G. F. and Brazhnikova, M. G. (1944) Gramicidin S. Origin and mode of action. Lancet, 247, 715-716.
79. Grage, S. L., Suleymanova, A. V., Afonin, S., et al. (2006) Solid state NMR analysis of the dipolar couplings within and between distant CF3- groups in a membrane- bound peptide. Journal of Magnetic Resonance, 183, 77-86.
80. Afonin, S., Dürr, U. H. N., Wadhwani, P., et al. (2008) Solid state NMR structure analysis of the antimicrobial peptide gramicidin S in lipid membranes: concentration- dependent realignment and self-assembly as a ß -barrel, in Topics in Current Chemistry, 273, Bioactive Conformation (ed. T. Peteas) Springer, Berlin, pp. 139-154.
81. Soravia, E., Martini, G. and Zasloff, M. (1988) Antimicrobial properties of peptides from Xenopus granular gland secretions. FEBS Letters, 228, 337-340.
82. Zasloff, M. (1987) Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proceedings of the National Academy of Sciences of the U. S. A., 84, 5449-5453.
83. Bechinger, B., Zasloff, M. and Opella, S. J. (1998) Structure and dynamics of the antibiotic peptide PGLa in membranes by solution and solid-state nuclear magnetic resonance spectros-copy. Biophysical Journal, 74, 981-987.
84. Afonin, S., Grage, S. L., Ieronimo, M., et al. (2008) Temperature-dependent transmembrane insertion of the amphiphilic PGLa in lipid bilayers observed by solid state 19F-NMR. Journal of the American Chemical Society, 130, 16512-16514.
85. Ieronimo, M. (2008) Towards the activity of the antimicrobialpeptide PGLa in cell membranes. Solid-state NMR studies of PGLa and magainin2, Ph.D. thesis, University of Karlsruhe.
86. Blazyk, J., Wiegand, R., Klein, J., et al. (2001) A novel linear amphipathic ß-sheet cationic antimicrobial peptide with enhanced selectivity for bacterial lipids. Journal of Biological Chemistry, 276, 27899-27906.
87. Maloy, W. L. and Kari, U. P. (1995) Structure-activity studies on magainins and other host -defense peptides. Biopolymers, 37, 105-122.
88. Toke, O., Maloy, W. L., Kim, S. J., et al. (2004) Secondary structure and lipid contact of a peptide antibiotic in phospholipid bilayers by REDOR. Biophysical Journal, 87, 662-674.
89. Kanithasen, N. (2005) 2H- and 19F-solid-state NMR studies of the antimicrobial peptide (KIAGKIA)3 in phospholipid bilayers, Diploma thesis, University of Karlsruhe.
90. Steiner, V., Schar, M., Bornsen, K. O. and Mutter, M. (1991) Retention behaviour of a template-assembled synthetic protein and its amphiphilic building blocks on reversed-phase columns. Journal of Chromatography, 586, 43-50.
91. Oehlke, J., Scheller, A., Wiesner, B., et al. (1998) Cellular uptake of an a-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochimica et Biophysica Acta, 1414, 127-139.
92. Vives, E., Brodin, P. and Lebleu, B. (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. Journal of Biological Chemistry, 272, 16010-16017.
93. Afonin, S., Frey, A., Bayerl, S., et al. (2006) The cell-penetrating peptide TAT(48-60) induces a non-lamellar phase in DMPC membranes. Chemphyschem, 7, 2134-2142.
94. Hofmann, A. and Glabe, C. (1994) Bindin, a multifunctional sperm ligand and the evolution of a new species. Seminars in Developmental Biology, 5, 233-242.
95. Vacquier, V. D., Swanson, W. J. and Hellberg, M. E. (1995) What have we learned about sea-urchin sperm bindin. Development Growth & Differentiation, 37, 1-10.
96. Ulrich, A. S., Tichelaar, W., Förster, G., et al. (1999) Ultrastructural characterization of peptide-induced membrane fusion and peptide self-assembly in the bilayer. Biophysical Journal, 77, 829-841.
97. Binder, H., Arnold, K., Ulrich, A. S. and Zschörnig, O. (2000) The effect of Zn2+ on the secondary structure of a histidine-rich fusogenic peptide and its interaction with lipid membranes. Biochimica et Biophysica Acta, 1468, 345-358.
98. Binder, H., Arnold, K., Ulrich, A. S. and Zschörnig, O. (2001) Interaction of Zn2+ with phos-pholipid membranes. Biophysical Chemistry, 90, 57-74.
99. Barre, P., Zschörnig, O., Arnold, K. and Huster, D. (2003) Structural and dynamical changes of the bindin B18 peptide upon binding to lipid membranes. A solid-state NMR study. Biochemistry, 42, 8377-8386.
100. Glaser, R. W., Grüne, M., Wandelt, C. and Ulrich, A. S. (1999) NMR and CD structural analysis of the fusogenic peptide sequence B18 from the fertilization protein bindin. Biochemistry, 38, 2560-2569.
101. Weissenhorn, W., Dessen, A., Harrison, S. C., et al. (1997) Atomic structure of the ectodomain from HIV-1 gp41. Nature, 387, 426-430.
102. Nieva, J. L., Nir, S., Muga, A., et al. (1994) Interaction of the HIV- 1 fusion peptide with phospholipid-vesicles-different structural requirements for fusion and leakage. Biochemistry, 33, 3201-3209.
103. Kliger, Y., Aharoni, A., Rapaport, D., et al. (1997- Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell fusion. Structure-function study. Journal of Biological Chemistry, 272, 13496-13505.
104. Martin, I., Defrise-Quertain, F., Decroly, E., et al. (1993) Orientation and structure of the NH2--erminal HIV-1 gp41 peptide in fused and aggregated liposomes. Biochimica et Biophysica Acta, 1145, 124-133.
105. Martin, I., Schaal, H., Scheid, A. and Ruysschaert, J. M. (1996) Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer. Journal of Virology, 70, 298-304.
106. Yang, J., Gabrys, C. M. and Weliky, D. P. (2001) Solid-state nuclear magnetic resonance evidence for an extended beta strand conformation of the membrane- bound HIV- 1 fusion peptide. Biochemistry, 40, 8126-8137.
107. Yang, J., Prorok, M., Castellino, F. J. and Weliky, D. P. (2004) Oligomeric ß-structure of the membrane-bound HIV-1 fusion peptide formed from soluble monomers. Biophysical Journal, 87, 1951-1963.
108. Yang, J. and Weliky, D. P. (2003) Solid-state nuclear magnetic resonance evidence for parallel and antiparallel strand arrangements in the membrane- associated HIV- 1 fusion peptide. Biochemistry, 42, 11879-11890.
109. Reichert, J., Grasnick, D., Afonin, S., et al. (2007) A critical evaluation of the conformational requirements of fusogenic peptides in membranes. European Biophysics Journal with Biophysics Letters, 36, 405-413.
110. Wadhwani, P., Bürck, J., Strandberg, E., et al. (2008) Using a sterically restrictive amino acid as a 19F NMR label to monitor and to control peptide aggregation in membranes. Journal of the American Chemical Society, 130, 16515-16517.